Litcius/Paper detail

Coagulation factor X promotes resistance to androgen-deprivation therapy in prostate cancer

Bianca Calì, Martina Troiani, Silvia Bressan, Giuseppe Attanasio, Sara Merler, Viola Moscarda, Simone Mosole, Elena Ricci, Christina Guo, Wei Yuan, Lewis Gallagher, Arian Lundberg, Ilona Bernett, Ines Figueiredo, Rydell Alvarez Arzola, Ernesto Bermudez Abreut, Mariantonietta D’Ambrosio, Nicolò Bancaro, Daniela Brina, Sara Zumerle, Emiliano Pasquini, Martino Maddalena, Ping Lai, Manuel Colucci, Nicolò Pernigoni, Andrea Rinaldi, Davide Minardi, Alessandro Morlacco, Fabrizio Moro, Marianna Sabbadin, Francesca Galuppini, Matteo Fassan, Jan H. Rüschoff, Holger Moch, Pasquale Rescigno, Edoardo Francini, Calogero Saieva, Mikol Modesti, Jean‐Philippe Theurillat, Silke Gillessen, Petra Wilgenbus, Claudine Graf, Wolfram Ruf, Johann S. de Bono, Andrea Alimonti

2024Cancer Cell15 citationsDOIOpen Access PDF

Topics & Concepts

Prostate cancerAndrogen deprivation therapyCoagulationProstateCancerCancer researchAndrogenMedicineInternal medicineOncologyBiologyEndocrinologyHormoneProstate Cancer Treatment and ResearchBlood Coagulation and Thrombosis MechanismsHormonal and reproductive studies
Coagulation factor X promotes resistance to androgen-deprivation therapy in prostate cancer | Litcius